These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8287597)

  • 61. Adoptive transfer of resistance to murine retrovirus-induced immune suppression.
    Gilmore GL
    Cell Immunol; 1996 Apr; 169(1):24-9. PubMed ID: 8612290
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
    Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
    J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The influence of macrophages on the leukemogenic activity of Rauscher murine leukemia virus].
    Sydow G; Sydow H
    Arch Geschwulstforsch; 1990; 60(4):279-82. PubMed ID: 2390004
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Successful therapy of viral leukemia by transplantation of histocompatibly unmatched marrow.
    Meredith RF; Okunewick JP; Kuhnert PM; Brozovich BJ; Weaver EV
    Exp Hematol; 1978 Mar; 6(3):273-82. PubMed ID: 25780
    [No Abstract]   [Full Text] [Related]  

  • 65. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modification of hemopoietic stem cells of BALB/c mice by Rauscher leukemia virus.
    Van Beek HJ; Van Hull E; Van Griensven LJ
    Exp Hematol; 1976 May; 4(3):151-60. PubMed ID: 773652
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 68. [Effect of Mycoplasma arthritidis and Rauscher leukosis virus on murine peritoneal macrophages in vitro and in vivo].
    Maslova TN; Sanin AV; Khorobrykh VV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Apr; (4):61-5. PubMed ID: 7080761
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
    Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S; Kamisaku H; Sado T
    Bone Marrow Transplant; 1995 Oct; 16(4):603-9. PubMed ID: 8528179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Friend leukemia virus-induced leukemogenesis in fully H-2 incompatible C57BL/6-->C3H radiation bone marrow chimeras.
    Kitagawa M; Kamisaku H; Sado T; Kasuga T
    Leukemia; 1993 Jul; 7(7):1041-6. PubMed ID: 8321019
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice.
    Black Pl; Ussery MA; Barney S; Wittrock R; DeMarsh P; Dreyer GB; Petteway SR; DalMonte P; Baldoni J; Lambert D
    Antiviral Res; 1996 Mar; 29(2-3):175-86. PubMed ID: 8739597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Optimization of the reverse transcriptase assay for the detection of viral burden in mice infected with Rauscher murine leukemia virus.
    White EL; Westbrook L; Hollingshead MG; Shannon WM
    J Virol Methods; 1996 Oct; 62(1):63-70. PubMed ID: 8910649
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Susceptibility of mice reconstituted with trisomy 19 hematopoietic cells to infection with Rauscher leukemia virus.
    Herbst EW; Gropp A; Pluznik DH
    J Cancer Res Clin Oncol; 1985; 109(2):107-14. PubMed ID: 4038980
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diffusion chamber hematopoiesis in marrow and spleen cells from mice infected with Rauscher leukemia virus (RLV-A).
    Koltun LA; Lobue J; Fredrickson TN; Gordon AS
    J Surg Oncol; 1976; 8(4):333-8. PubMed ID: 948202
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interferon and host resistance to Rauscher virus-induced leukemia.
    Glasgow LA; Friedman SB
    J Virol; 1969 Feb; 3(2):99-105. PubMed ID: 5774143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure.
    Ruprecht RM; Chou TC; Chipty F; Sosa MG; Mullaney S; O'Brien L; Rosas D
    J Acquir Immune Defic Syndr (1988); 1990; 3(6):591-600. PubMed ID: 2159992
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of tamoxifen, droloxifene and 17 beta-estradiol on Rauscher mouse leukemogenesis.
    Sydow G; Wunderlich V
    Cancer Lett; 1994 Jul; 82(1):89-94. PubMed ID: 8033074
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potentiation of leukemogenicity and infectivity of Rauscher leukemia virus by an enhancing factor present in egg fluids.
    Gazit A; Eylan E; Rosen N; Samucha R
    Exp Cell Biol; 1979; 47(1):29-42. PubMed ID: 437243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.